Kenvue Inc
Research Kenvue Inc (KVUE) on Bullrun: valuation model: 3.7% undervalued, market cap USD 37.12B, P/E 22.4, dividend yield 4.3%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerKVUE
- ExchangeNYSE
- CountryUnited States
- SectorConsumer Defensive
- IndustryHousehold & Personal Products
- CurrencyUSD
- Valuation signal3.7% undervalued
- Market capUSD 37.12B
- P/E22.4
- Dividend yield4.3%
- Financial periodQ2 2026
- RevenueUSD 3.96B
- Net incomeUSD 456.00M
- Free cash flowUSD 624.00M
- Gross margin58.2%
Valuation Snapshot
Bullrun's latest valuation model marks Kenvue Inc as 3.7% undervalued; latest market cap is USD 37.12B; P/E is 22.4; dividend yield is 4.3%.
Peer valuation comparison
Latest P/E is 22.41x versus a Consumer Defensive sector median of 17.41x (28.7% above).
Latest dividend yield is 4.34% versus a Consumer Defensive sector median of 3.04% (42.8% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 15.12B | USD 1.47B | USD 1.72B | 58.1% | 0.76 | USD 1.06B | USD 1.45B | USD 10.77B |
| FY2024 | USD 15.46B | USD 1.03B | USD 1.34B | 58.0% | 0.54 | USD 1.07B | USD 1.55B | USD 9.67B |
| FY2023 | USD 15.44B | USD 1.66B | USD 2.70B | 56.0% | 0.9 | USD 1.38B | USD 8.29B | USD 11.21B |
| FY2022 | USD 15.05B | USD 2.08B | USD 39.00M | 55.9% | 1.21 | USD 740.00M | n/a | USD 20.49B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 37.12B | 22.4 | 4.3% | 0.83 |
| 2025 | 2025-12-31 | USD 33.05B | 22.7 | 4.9% | 0.84 |
| 2024 | 2024-12-31 | USD 40.86B | 39.5 | 3.8% | 0.82 |
| 2023 | 2023-12-29 | USD 41.23B | 23.4 | 1.9% | 0.4 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.83 USD, yield 4.3%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.83 USD |
| FY2024 | 0.81 USD |
| FY2023 | 0.4 USD |
About Kenvue Inc
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine;
Related stock research
Other Consumer Defensive stocks
Frequently asked questions
Is Kenvue Inc overvalued or undervalued?
Bullrun's valuation model currently marks Kenvue Inc as 3.7% undervalued.
What is Kenvue Inc's market cap?
Kenvue Inc's market capitalization is USD 37.12B.
What is Kenvue Inc's P/E ratio?
Kenvue Inc's price-to-earnings (P/E) ratio is 22.4.
Does Kenvue Inc pay a dividend?
Kenvue Inc has a dividend yield of 4.3%.
What does Kenvue Inc do?
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health.